Ab&B Bio-Tech CO., LTD. JS (HKG:2627)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
40.42
-0.30 (-0.74%)
At close: Dec 5, 2025
Market Cap 15.90B
Revenue (ttm) 354.77M
Net Income (ttm) -245.92M
Shares Out 393.44M
EPS (ttm) -0.68
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 175,000
Average Volume 184,903
Open 40.04
Previous Close 40.72
Day's Range 40.02 - 41.30
52-Week Range 33.00 - 59.60
Beta n/a
RSI 47.40
Earnings Date Nov 28, 2025

About HKG:2627

Ab&B Bio-Tech CO., LTD. JS researchs, develops, manufactures, and sells vaccines and biological preparations that provide active immunity against diseases. The company offers various vaccines, such as human rabies vaccine, pneumococcal vaccine, zoster vaccine, respiratory syncytial virus vaccine, mpox vaccine, varicella vaccine, and tetanus vaccine. The company was founded in 2015 and is based in Taizhou, China. [Read more]

Sector Healthcare
Founded 2015
Employees 583
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2627
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.